Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 19.56
(0.88%)
CNY 19.56
(0.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 648.81 Million CNY | -7.29% |
| 2022 | 699.86 Million CNY | 9.22% |
| 2021 | 640.76 Million CNY | 20.81% |
| 2020 | 530.37 Million CNY | 14.96% |
| 2019 | 461.35 Million CNY | 5.0% |
| 2018 | 439.38 Million CNY | 37.72% |
| 2017 | 319.03 Million CNY | 19.35% |
| 2016 | 267.3 Million CNY | 9.35% |
| 2015 | 244.44 Million CNY | 11.4% |
| 2014 | 219.43 Million CNY | 32.86% |
| 2013 | 165.16 Million CNY | 62.94% |
| 2012 | 101.36 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 93.89 Million CNY | -48.74% |
| 2024 Q1 | 183.15 Million CNY | -8.72% |
| 2024 Q3 | 93.45 Million CNY | -0.47% |
| 2023 Q4 | 200.64 Million CNY | 39.94% |
| 2023 Q3 | 143.37 Million CNY | 8.14% |
| 2023 FY | 648.81 Million CNY | -7.29% |
| 2023 Q1 | 172.2 Million CNY | -35.9% |
| 2023 Q2 | 132.58 Million CNY | -23.01% |
| 2022 Q4 | 268.63 Million CNY | 100.21% |
| 2022 Q2 | 122.93 Million CNY | -29.4% |
| 2022 Q1 | 174.11 Million CNY | -28.65% |
| 2022 FY | 699.86 Million CNY | 9.22% |
| 2022 Q3 | 134.17 Million CNY | 9.14% |
| 2021 Q3 | 134.27 Million CNY | 15.33% |
| 2021 Q4 | 244.05 Million CNY | 81.75% |
| 2021 Q1 | 146 Million CNY | -28.82% |
| 2021 Q2 | 116.42 Million CNY | -20.26% |
| 2021 FY | 640.76 Million CNY | 20.81% |
| 2020 Q2 | 85.7 Million CNY | -21.2% |
| 2020 Q3 | 130.8 Million CNY | 52.63% |
| 2020 FY | 530.37 Million CNY | 14.96% |
| 2020 Q4 | 205.11 Million CNY | 56.8% |
| 2020 Q1 | 108.75 Million CNY | -36.8% |
| 2019 Q3 | 73.84 Million CNY | -0.56% |
| 2019 FY | 461.35 Million CNY | 5.0% |
| 2019 Q4 | 172.06 Million CNY | 133.01% |
| 2019 Q2 | 74.26 Million CNY | -47.4% |
| 2019 Q1 | 141.17 Million CNY | -11.76% |
| 2018 Q1 | 109.68 Million CNY | -7.96% |
| 2018 FY | 439.38 Million CNY | 37.72% |
| 2018 Q4 | 159.98 Million CNY | 93.54% |
| 2018 Q3 | 82.66 Million CNY | -5.05% |
| 2018 Q2 | 87.05 Million CNY | -20.63% |
| 2017 FY | 319.03 Million CNY | 19.35% |
| 2017 Q1 | 75.24 Million CNY | -20.02% |
| 2017 Q2 | 68.44 Million CNY | -9.04% |
| 2017 Q3 | 56.17 Million CNY | -17.93% |
| 2017 Q4 | 119.17 Million CNY | 112.15% |
| 2016 Q1 | 71.02 Million CNY | 0.0% |
| 2016 Q4 | 94.08 Million CNY | 90.33% |
| 2016 FY | 267.3 Million CNY | 9.35% |
| 2016 Q3 | 49.43 Million CNY | -6.33% |
| 2016 Q2 | 52.77 Million CNY | -25.7% |
| 2015 FY | 244.44 Million CNY | 11.4% |
| 2014 FY | 219.43 Million CNY | 32.86% |
| 2013 FY | 165.16 Million CNY | 62.94% |
| 2012 FY | 101.36 Million CNY | 0.0% |